Deal date
KANDO id: 610851
Financial Transaction:
Series C
Avelas Biosciences Inc
Currency
United States Dollar
Value in original currency
20,000,000
Value in USD
20,000,000
Lead investor
| Investor | Country | Notes | |
|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Pharmastandard |
Round participants
| Investor | Country | Notes | |
|---|---|---|---|
|
|
Alexandria Venture Investments |
||
|
Avalon Ventures |
United States | |
|
|
Bregua Corp |
||
|
|
Ervington Investments |
||
|
|
WuXi Healthcare Ventures |